4.7 Article

Niclosamide Attenuates Inflammation-Associated Profibrotic Responses in Human Subepithelial Lung Myofibroblasts

Related references

Note: Only part of the references are listed.
Article Cell Biology

Niclosamide Ethanolamine Salt Alleviates Idiopathic Pulmonary Fibrosis by Modulating the PI3K-mTORC1 Pathway

Xiaolin Pei et al.

Summary: Idiopathic pulmonary fibrosis (IPF) is a serious disease that leads to respiratory failure and early mortality. This study found that Niclosamide ethanolamine salt (NEN) could significantly improve lung function and reduce fibrosis in an IPF animal model. The results also showed that NEN inhibits abnormal fibroblast proliferation and excessive extracellular matrix production through the regulation of the PI3K-mTORC1 and autophagy pathways. These findings provide strong evidence for the potential therapeutic role of NEN in IPF.

CELLS (2022)

Article Biochemistry & Molecular Biology

Anti-Inflammatory and Anti-Fibrotic Effect of Immortalized Mesenchymal-Stem-Cell-Derived Conditioned Medium on Human Lung Myofibroblasts and Epithelial Cells

Eirini Filidou et al.

Summary: Idiopathic pulmonary fibrosis (IPF) is a progressive lung disease with no known effective treatment. Researchers have found that conditioned media (CM) from an immortalized human adipose mesenchymal stem cell line can have anti-inflammatory and anti-fibrotic effects on pulmonary cells. CM reduces the production of chemokines and collagen Type III, and inhibits the migration of myofibroblasts.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Pharmacology & Pharmacy

Disturbance of the Warburg effect by dichloroacetate and niclosamide suppresses the growth of different sub-types of malignant pleural mesothelioma in vitro and in vivo

Sze-Kwan Lam et al.

Summary: The combination of dichloroacetate and niclosamide shows a significant inhibitory effect on the growth and migration of malignant pleural mesothelioma cells. This combination therapy also reduces tumor growth in vivo.

FRONTIERS IN PHARMACOLOGY (2022)

Article Pharmacology & Pharmacy

Targeting Wnt/β-catenin by anthelmintic drug niclosamide overcomes paclitaxel resistance in esophageal cancer

Wei Wei et al.

Summary: Esophageal cancer is a highly aggressive malignancy with high rates of recurrence. Niclosamide, an anthelmintic drug, shows potential as a sensitizing agent to overcome chemoresistance in esophageal cancer, particularly in combination with paclitaxel. Mechanistically, niclosamide inhibits Wnt/beta-catenin signaling and shows efficacy in inhibiting proliferation and inducing apoptosis in paclitaxel-resistant esophageal cancer cells.

FUNDAMENTAL & CLINICAL PHARMACOLOGY (2021)

Review Rheumatology

Mechanisms of progressive fibrosis in connective tissue disease (CTD)-associated interstitial lung diseases (ILDs)

Paolo Spagnolo et al.

Summary: This study discusses the different types of interstitial lung diseases (ILDs) and their association with autoimmune and connective tissue diseases (CTDs), as well as introduces drug treatment studies for some fibrosing ILDs. It emphasizes the importance of fibrosis in ILDs.

ANNALS OF THE RHEUMATIC DISEASES (2021)

Article Chemistry, Medicinal

Dihydroartemisinin Inhibits TGF-β-Induced Fibrosis in Human Tenon Fibroblasts via Inducing Autophagy

Xiaoyuan Wang et al.

Summary: This study demonstrated that DHA inhibits TGF-β-induced fibrosis of HTFs by inducing autophagy. Additionally, DHA induces apoptosis and increases ROS levels in HTFs, partially reversing the effects of TGF-β. Furthermore, DHA upregulates the expression of miR-145-5p in HTFs in a dose-dependent manner, which may help prevent the formation of hypertrophic scars following glaucoma surgery.

DRUG DESIGN DEVELOPMENT AND THERAPY (2021)

Review Respiratory System

Efficacy of antifibrotic drugs, nintedanib and pirfenidone, in treatment of progressive pulmonary fibrosis in both idiopathic pulmonary fibrosis (IPF) and non-IPF: a systematic review and meta-analysis

James Patrick Finnerty et al.

Summary: This study compared the efficacy of nintedanib and pirfenidone in the treatment of progressive pulmonary fibrosis, finding that anti-fibrotic therapy can slow the decline in forced vital capacity in both IPF and non-IPF patients. However, there was insufficient data to confirm a reduction in mortality in non-IPF patients with anti-fibrotic therapy.

BMC PULMONARY MEDICINE (2021)

Article Biochemistry & Molecular Biology

Kurarinone Attenuates BLM-Induced Pulmonary Fibrosis via Inhibiting TGF-β Signaling Pathways

Soo-Jin Park et al.

Summary: Idiopathic pulmonary fibrosis (IPF) is a difficult-to-treat interstitial lung disease with no effective treatment currently available. Kurarinone, a flavonoid isolated from Sophora Flavescens, has shown therapeutic potential in attenuating lung fibrosis by suppressing TGF-beta signaling pathways. This study suggests that Kurarinone may serve as a novel drug candidate for pulmonary fibrosis.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Cell Biology

Pirfenidone modulates macrophage polarization and ameliorates radiation-induced lung fibrosis by inhibiting the TGF-β1/Smad3 pathway

Hangjie Ying et al.

Summary: The study found that pirfenidone (PFD) has potential therapeutic effects in ameliorating fibrosis in radiation-induced lung fibrosis (RILF) by reducing M2 macrophage infiltration and inhibiting the activation of the TGF-beta 1/Smad3 signaling pathway.

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2021)

Review Genetics & Heredity

The interplay of DAMPs, TLR4, and proinflammatory cytokines in pulmonary fibrosis

Siavash Bolourani et al.

Summary: Pulmonary fibrosis is a chronic condition characterized by progressive deposition of connective tissue, leading to a decline in lung elasticity and function. Common causes include inhalation of foreign particles, infections, autoimmune diseases, and idiopathic pulmonary fibrosis. Current therapeutics only modestly slow disease progression. This review focuses on the interplay of DAMP molecules, TLR4, and inflammatory cytokines in the pathogenesis of pulmonary fibrosis and explores potential avenues for developing effective therapeutics.

JOURNAL OF MOLECULAR MEDICINE-JMM (2021)

Article Immunology

Targeting S100A4 with niclosamide attenuates inflammatory and profibrotic pathways in models of amyotrophic lateral sclerosis

Martina Milani et al.

Summary: The study reveals that S100A4 plays a role in ALS-related mechanisms, and drugs like niclosamide targeting inflammatory and fibrotic pathways could be promising pharmacological tools for ALS treatment.

JOURNAL OF NEUROINFLAMMATION (2021)

Review Pharmacology & Pharmacy

Therapeutic targets in lung tissue remodelling and fibrosis

Gang Liu et al.

Summary: Structural changes involving tissue remodelling and fibrosis are major features of many pulmonary diseases. Understanding the differences and similarities of remodelling can help identify common therapeutic targets and strategies for diseases like asthma, COPD, and IPF. Targeting transforming growth factor (TGF)-beta induced fibroblast activation may be a central pathway in the remodelling process.

PHARMACOLOGY & THERAPEUTICS (2021)

Article Toxicology

The ameliorative effect of niclosamide on bile duct ligation induced liver fibrosis via suppression of NOTCH and Wnt pathways

Manar M. Esmail et al.

Summary: Niclosamide shows promising potential as an antifibrotic agent in CLF through inhibition of NOTCH and Wnt pathways, reducing liver enzymes levels, oxidative stress, inflammation, and fibrosis markers.

TOXICOLOGY LETTERS (2021)

Review Chemistry, Medicinal

Broad Spectrum Antiviral Agent Niclosamide and Its Therapeutic Potential

Jimin Xu et al.

ACS INFECTIOUS DISEASES (2020)

Article Cell Biology

The myofibroblast at a glance

Pardis Pakshir et al.

JOURNAL OF CELL SCIENCE (2020)

Review Multidisciplinary Sciences

Fibrosis: from mechanisms to medicines

Neil C. Henderson et al.

NATURE (2020)

Review Biochemistry & Molecular Biology

Molecular Mechanisms of Pulmonary Fibrogenesis and Its Progression to Lung Cancer: A Review

Tomonari Kinoshita et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)

Review Pharmacology & Pharmacy

Niclosamide repositioning for treating cancer: Challenges and nano-based drug delivery opportunities

Eduardo Jose Barbosa et al.

EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2019)

Article Respiratory System

Pharmacotherapy and adjunctive treatment for idiopathic pulmonary fibrosis (IPF)

Shigeki Saito et al.

JOURNAL OF THORACIC DISEASE (2019)

Review Cardiac & Cardiovascular Systems

Inflammation and immunity in IPF pathogenesis and treatment

P. Heukels et al.

RESPIRATORY MEDICINE (2019)

Article Psychiatry

Niclosamide piperazine prevents high-fat diet-induced obesity and diabetic symptoms in mice

Jingjing Guo et al.

EATING AND WEIGHT DISORDERS-STUDIES ON ANOREXIA BULIMIA AND OBESITY (2019)

Article Medicine, Research & Experimental

Niclosamide repurposed for the treatment of inflammatory airway disease

Ines Cabrita et al.

JCI INSIGHT (2019)

Article Chemistry, Medicinal

Niclosamide, a Drug with Many (Re)purposes

Hachemi Kadri et al.

CHEMMEDCHEM (2018)

Review Respiratory System

Idiopathic pulmonary fibrosis: pathogenesis and management

Giacomo Sgalla et al.

RESPIRATORY RESEARCH (2018)

Article Medicine, General & Internal

Idiopathic pulmonary fibrosis

Fernando J. Martinez et al.

NATURE REVIEWS DISEASE PRIMERS (2017)

Review Cell Biology

Niclosamide: Beyond an antihelminthic drug

Wei Chen et al.

CELLULAR SIGNALLING (2017)

Article Multidisciplinary Sciences

Drug repurposing in idiopathic pulmonary fibrosis filtered by a bioinformatics-derived composite score

E. Karatzas et al.

SCIENTIFIC REPORTS (2017)

Article Immunology

Niclosamide induces apoptosis in human rheumatoid arthritis fibroblast-like synoviocytes

Mingcheng Huang et al.

INTERNATIONAL IMMUNOPHARMACOLOGY (2016)

Article Biochemistry & Molecular Biology

Transforming Growth Factor (TGF)-β Promotes de Novo Serine Synthesis for Collagen Production

Recep Nigdelioglu et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2016)

Article Dermatology

Improvement of Sclerodermatous Graft-Versus-Host Disease in Mice by Niclosamide

Florence Morin et al.

JOURNAL OF INVESTIGATIVE DERMATOLOGY (2016)

Review Respiratory System

Mode of action of nintedanib in the treatment of idiopathic pulmonary fibrosis

Lutz Wollin et al.

EUROPEAN RESPIRATORY JOURNAL (2015)

Article Multidisciplinary Sciences

TNF-α-stimulated fibroblasts secrete lumican to promote fibrocyte differentiation

Darrell Pilling et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)

Review Medicine, General & Internal

Idiopathic Pulmonary Fibrosis: Evolving Concepts

Jay H. Ryu et al.

MAYO CLINIC PROCEEDINGS (2014)

Article Pathology

Pathogenesis of Idiopathic Pulmonary Fibrosis

Paul J. Wolters et al.

Annual Review of Pathology-Mechanisms of Disease (2013)

Review Oncology

The myofibroblast matrix: implications for tissue repair and fibrosis

Franco Klingberg et al.

JOURNAL OF PATHOLOGY (2013)

Article Cell Biology

Caspase Functions in Cell Death and Disease

David R. McIlwain et al.

COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2013)

Review Physiology

Genetically manipulated mouse models of lung disease: potential and pitfalls

Rebecca M. Baron et al.

AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2012)

Review Biochemistry & Molecular Biology

Mechanisms of fibrosis: therapeutic translation for fibrotic disease

Thomas A. Wynn et al.

NATURE MEDICINE (2012)

Article Biochemical Research Methods

Fiji: an open-source platform for biological-image analysis

Johannes Schindelin et al.

NATURE METHODS (2012)

Review Physiology

Wnt/beta-Catenin Signaling: a Promising New Target for Fibrosis Diseases

Y. Guo et al.

PHYSIOLOGICAL RESEARCH (2012)

Review Biochemistry & Molecular Biology

Myofibroblast differentiation and survival in fibrotic disease

Kornelia Kis et al.

EXPERT REVIEWS IN MOLECULAR MEDICINE (2011)

Article Dermatology

Fibroblasts and myofibroblasts in wound healing: Force generation and measurement

Bin Li et al.

JOURNAL OF TISSUE VIABILITY (2011)

Review Respiratory System

Antifibrotic activities of pirfenidone in animal models

C. J. Schaefer et al.

EUROPEAN RESPIRATORY REVIEW (2011)

Review Biochemistry & Molecular Biology

The role of inflammation in the pathogenesis of idiopathic pulmonary fibrosis

Benjamin D. Bringardner et al.

ANTIOXIDANTS & REDOX SIGNALING (2008)

Article Multidisciplinary Sciences

Functional Wnt Signaling Is Increased in Idiopathic Pulmonary Fibrosis

Melanie Koenigshoff et al.

PLOS ONE (2008)

Article Biochemistry & Molecular Biology

Analysis of gene expression and chemoresistance of CDI33+ cancer stem cells in glioblastoma

Gentao Liu et al.

MOLECULAR CANCER (2006)